Michael DEBAUN
Vanderbilt University School of Medicine
State of Sickle Cell Disease: Progress and challenges - USA
Friday, June 17th 10:06 - 10:18 UTC+2
Friday, June 17th 11:00 - 11:30 UTC+2
Session 12: How to increase teaching of Sickle Cell Disease?
Friday, June 17th 11:00 - 12:30 UTC+2
Session 17: Neurological complications
Friday, June 17th 16:00 - 17:30 UTC+2
Screening and treatment in Africa
Friday, June 17th 17:00 - 17:30 UTC+2
Dr. Michael R. DeBaun is Professor of Pediatrics and Medicine at Vanderbilt University School of Medicine and the JC Peterson Endowed Chair in Pediatrics. He is the Founder and Director of the Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease.
.
Dr. DeBaun is an internationally recognized physician-scientist whose advocacy and research have resulted in fundamental advances in the medical care of children and adults with sickle cell disease. For over 20 years, his efforts in sickle cell disease have focused on epidemiology, cognitive impact, clinical significance, and strategies for preventing strokes and silent strokes in children and adults with sickle cell disease. He has been the principal investigator or co-chair of 8 NIH or Foundation-funded (Doris Duke, Thrasher) controlled clinical trials designed to prevent strokes or stroke recurrence in children and adults with sickle cell disease in North America, Europe, and Nigeria.